Evidence map›Paper›PMID 28005533›Full record

ArticleEBioMedicine2016

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes.

Shinji Kume, Motoyuki Kondo, Shiro Maeda, Yoshihiko Nishio, Tsuyoshi Yanagimachi, Yukihiro Fujita, Masakazu Haneda, Keiko Kondo, Akihiro Sekine, Shin-Ich Araki and 9 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Leptin Influence Cholelithiasis Formation by Regulating Bile Acid Metabolism.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Hypothalamic AMPK as a Mediator of Hormonal Regulation of Energy Balance.International journal of molecular sciences · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Shinji KumeDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan. Electronic address: skume@belle.shiga-med.ac.jp.
Motoyuki KondoDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Shiro MaedaLaboratory for Endocrinology and Metabolism, RIKEN Center for Genomic Medicine, Yokohama, Kanagawa 230-0045, Japan; Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, Uehara, Nishihara-cho, Nakagami-gun, Okinawa 903-0215, Japan; Division of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Uehara, Nishihara-cho, Nakagami-gun, Okinawa 903-0215, Japan.
Yoshihiko NishioDivision of Diabetes, Metabolism and Endocrinology, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka, Kagoshima 890-8580, Japan.
Tsuyoshi YanagimachiDivision of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.
Yukihiro FujitaDivision of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.
Masakazu HanedaDivision of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.
Keiko KondoDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan; Department of Public Health, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Akihiro SekineChiba University, Center for Preventive Medical Science. 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-0856, Japan.
Shin-Ich ArakiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hisazumi ArakiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Masami Chin-KanasakiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Satoshi UgiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Daisuke KoyaDivision of Diabetology & Endocrinology, Kanazawa Medical University, Kahoku-gun, Ishikawa 920-1192, Japan.
Sawako KitaharaKusatsu General Hospital, Kusatsu, Shiga 525-0066, Japan.
Kiyosumi MaedaKusatsu General Hospital, Kusatsu, Shiga 525-0066, Japan.
Atsunori KashiwagiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan; Kusatsu General Hospital, Kusatsu, Shiga 525-0066, Japan.
Takashi UzuDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hiroshi MaegawaDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan. Electronic address: maegawa@belle.shiga-med.ac.jp.
Shiga University of Medical Science · JPAsahikawa Medical University · JPChiba University · JPKagoshima University · JPKanazawa Medical University · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose-stimulated insulin secretion (GSIS) by pancreatic β cells is biphasic. However, the physiological significance of biphasic GSIS and its relationship to diabetes are not yet fully understood. This study demonstrated that impaired first-phase GSIS follows fasting, leading to increased blood glucose levels and brain glucose distribution in humans. Animal experiments to determine a possible network between the brain and β cells revealed that fasting-dependent hyperactivation of AMP-activated protein kinase in the hypothalamus inhibited first-phase GSIS by stimulating the β-adrenergic pancreatic nerve. Furthermore, abnormal excitability of this brain-β cell neural axis was involved in diabetes-related impairment of first-phase GSIS in diabetic animals. Finally, pancreatic denervation improved first-phase GSIS and glucose tolerance and ameliorated severe diabetes by preventing β cell loss in diabetic animals. These results indicate that impaired first-phase GSIS is critical for brain distribution of dietary glucose after fasting. Furthermore, β cells in individuals with diabetes mistakenly sense that they are under conditions that mimic prolonged fasting. The present study provides additional insight into both β cell physiology and the pathogenesis of β cell dysfunction in type 2 diabetes.

Indexed as

AMP-Activated Protein KinasesAnimalsBrainDenervationDiabetes Mellitus, Type 2Disease Models, AnimalFastingFluorodeoxyglucose F18GlucoseGlucose Tolerance TestHumansHypothalamusInsulinsInsulin-Secreting CellsMaleOrgan SpecificityAMP-Activated Protein KinasesFluorodeoxyglucose F18GlucoseInsulinsDiabetesFirst-phase GSISInsulin secretionPancreatic ? cellStarvation

Identifiers

PMID28005533
PMCPMC5264491
OpenAlexW2540875909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.